Septerna, Inc.
Septerna, Inc. (SEPN): 3 pipeline candidates · ~40 mo cash runway · 2 clinical trials. Updated within the last hour.
BioSniper Score
5-factor signal · derived from public data
39.8 months
D/E 0.51 · 0% dilution
Lead: Phase 1
3 candidates
N/A
0 buys · 11 sells (180d)
A transparent, data-derived signal for Septerna, Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$1.6B
Cash
$71.6M
Quarterly Burn
$25.6M
Runway
39.8 mo
Revenue
$26.5M
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (3 candidates)
| Drug | Phase |
|---|---|
| pth1r agonist | Preclinical |
| sep-479 | Phase 1 |
| sep-631 | Phase 1 |
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
123
Total value held
$1.07B
| Holder | Shares | Value |
|---|---|---|
| ra capital management, l.p. | 6,995,858 | $168.1M |
| trv gp v, llc | 6,215,591 | $149.4M |
| driehaus capital management llc | 4,395,572 | $105.6M |
| trv gp vi, llc | 4,211,659 | $101.2M |
| samsara biocapital, llc | 3,149,128 | $75.7M |
| goldman sachs group inc | 2,906,427 | $69.8M |
| vanguard capital management llc | 2,393,924 | $57.5M |
| blackrock, inc. | 1,822,174 | $43.8M |
| janus henderson group plc | 1,781,508 | $42.7M |
| bvf inc/il | 1,353,249 | $32.5M |
Showing top 10 of 123 institutional holders of Septerna, Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in Septerna, Inc.'s pipeline?
Septerna, Inc. (SEPN) has 3 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is Septerna, Inc.'s lead drug candidate?
Septerna, Inc.'s most advanced tracked candidate is pth1r agonist (Preclinical) for hypoparathyroidism.
What is Septerna, Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Septerna, Inc. has approximately 39.8 months of cash runway.
What is Septerna, Inc.'s market capitalization?
Septerna, Inc.'s market capitalization is approximately $1.6B.
Who is the CEO of Septerna, Inc.?
Dr. Jeffrey T. Finer M.D., Ph.D. is the chief executive officer of Septerna, Inc. (SEPN).
Get the full picture on Septerna, Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.